心肺适能
有氧运动
随机对照试验
医学
物理疗法
帕金森病
物理医学与康复
康复
疾病
体育锻炼
磁共振成像
临床试验
最大VO2
生活质量(医疗保健)
评定量表
神经学
功能磁共振成像
运动生理学
神经黑素
中枢神经系统疾病
左旋多巴
干预(咨询)
不利影响
内科学
疾病严重程度
有氧能力
作者
Martin Langeskov‐Christensen,Mikkel Karl Emil Nygaard,Simon Fristed Eskildsen,Steffen Ringgaard,Jacob Geday,Erik Hvid Danielsen,Erik Johnsen,Cecilie Thrue,Frederik Bonde-Jensen,Lars G. Hvid,Ulrik Dalgas
标识
DOI:10.1177/15459683261448458
摘要
OBJECTIVES: Medical disease-modifying treatments are lacking in Parkinson's disease (PD). Physical exercise is potentially an inexpensive and easily accessible disease-modifying therapy, but this remains to be studied using recent promising magnetic resonance imaging (MRI) markers of disease progression. The objective was to determine whether 24 weeks of moderate to high-intensity progressive aerobic exercise affects brain MRI measures in people with PD (pwPD). METHODS: A 24-week randomized controlled multicenter trial (with a 24-week follow-up) was conducted, including an exercise group (supervised aerobic exercise followed by self-guided physical activity) and a control group (habitual lifestyle). Patients older than 40 years with mild to moderate impairments (Hoehn & Yahr score ≤3) were randomized (1:1). The primary outcome was R2* (effective transverse relaxation rate) after 24 weeks, which was analyzed using the intention-to-treat principle. Additional outcomes included free water and neuromelanin levels in the substantia nigra, cardiorespiratory fitness, the Movement Disorder Society-sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS), and levodopa equivalent daily dose (LEDD). RESULTS: Seventy participants were randomized to exercise (n = 36) or control (n = 34). R2* did not change over the intervention period (between-group difference: -1.14 [-5.14; 2.87], mean [95%CI]). Similarly, no significant effects were seen in cardiorespiratory fitness (+1.64 mL O2/min/kg [-0.23; 3.51]) and MDS-UPDRS III (-0.7 [-5.3; 4.0]), whereas LEDD increased less following exercise (-78.4 [-154.6; -2.1]). CONCLUSION: These findings do not support a neuroprotective effect of progressive aerobic exercise on R2* in pwPD, whereas the intervention appears to benefit the efficacy of levodopa. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT04379778.
科研通智能强力驱动
Strongly Powered by AbleSci AI